Brightech has experience in multiple therapeutic areas, particularly oncology, cardiovascular disease, infectious disease, gastrointestinal disorder, CNS and analgesics; We have collaborated in numerous FDA/EMEA submissions.
Our expertise in complex studies is demonstrated by our study portfolio, over 80% of which are in oncology.
Service | Projects | Phase | Therapeutic Areas |
|---|---|---|---|
Statistics and SAS programming (TFLs) | 100 | I-IV | Oncology, CNS, Infectious, etc. |
Data management (US/China) | 10/200 | I-III | Oncology, CNS, Obesity, Infectious |
Patient profile | 60 | I-IV | Oncology |
Protocol deviation checks via SAS programming | 45 | I-III | Oncology |
Data Standard Services (SDTM/ADaM/define.xml) | 100 | I-III | Oncology, MS, Osteoporosis |
Medical Writing (CSR, IB, ISS) | 10 | I-III | Oncology, Pain |
